Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged Receivables

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged (NVOH) currently reports a receivables of $820M as of September 2016. That compares with $580M in the prior-year period — up 42.4% year over year. Use the charts on this page to explore Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's receivables history and peer comparisons.

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's receivables increased from $580M to $820M — a 42.4% year-over-year increase (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged reported $820M in receivables as of September 2016. That compares with $580M in the prior-year period — up 42.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $820M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged, and consider following NVOH for alerts when major investors trade the stock.